Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients

December 16, 2009 updated by: University of Sao Paulo General Hospital
Objective: To investigate effects of home-based somatosensory stimulation associated with motor training on improvement in performance of the paretic upper extremity in patients in the chronic phase after stroke.

Study Overview

Detailed Description

Design: Double-blind, randomized, controlled clinical trial. Setting: Home-based rehabilitation. Subjects: Patients in the chronic phase (> 6 months) after stroke. Interventions: Patients will be randomized to an active and a control group. In both groups, treatments will be performed at home, daily, over four weeks. Patients in the active group will be instructed to use a device that provides somatosensory stimulation in the form of electrical stimulation of the median nerve for two hours. Patients in the control group will also be instructed to use the device for two hours, and sham stimulation will be administered. In both groups, patients will be instructed to train activities with the paretic hand immediately after nerve stimulation.

Main measures: The primary outcome will be improvement in performance of the paretic hand evaluated by the Jebsen-Taylor test at end of treatment and four months after end of treatment, compared to baseline. Secondary outcomes were: 1) Compliance with the interventions, assessed through a daily written log, and oral reports of the patients; 2) safety profile of the interventions.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • São Paulo, SP, Brazil, 55
        • University of São Paulo/General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 18-80 years;
  • single ischemic or hemorrhagic stroke in a cerebral hemisphere, documented by computed tomography (CT) or magnetic resonance imaging (MRI);
  • stroke onset at least six months before;
  • hand paresis with preserved ability to perform all tasks of the Jebsen-Taylor Test (JTT).

Exclusion Criteria:

  • previous strokes;
  • epilepsy and other neurological conditions;
  • proprioceptive or tactile anesthesia;
  • shoulder or hand pain;
  • severe joint deformity;
  • severe chronic disease;
  • inability to give provide informed consent due to severe aphasia or cognitive impairment;
  • left handedness before the stroke.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Somatosensory stimulation
Active group
Electrical median nerve stimulation
Other Names:
  • Relief band
Placebo Comparator: Control group
Placebo stimulation
Placebo stimulation
Other Names:
  • no stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the improvement in upper extremity performance assessed using Jebsen-Taylor test
Time Frame: Treatment lasted four weeks. Measures were performed before the treatment, immediately after the treatment and four months after the end of the treatment
Treatment lasted four weeks. Measures were performed before the treatment, immediately after the treatment and four months after the end of the treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
Compliance with the interventions, assessed through a daily written log, and oral reports of the patients
Time Frame: immediately after the treatment
immediately after the treatment
Adverse events
Time Frame: at end of treatment
at end of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adriana Conforto, MD PhD, Hospital das Clínicas/FMUSP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2007

Primary Completion (Actual)

September 1, 2009

Study Completion (Actual)

November 1, 2009

Study Registration Dates

First Submitted

December 11, 2009

First Submitted That Met QC Criteria

December 16, 2009

First Posted (Estimate)

December 17, 2009

Study Record Updates

Last Update Posted (Estimate)

December 17, 2009

Last Update Submitted That Met QC Criteria

December 16, 2009

Last Verified

November 1, 2009

More Information

Terms related to this study

Other Study ID Numbers

  • 1309-06
  • 477916/06-6 (Other Grant/Funding Number: CNPq)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Relief band (Somatosensory stimulation)

Subscribe